ACIP Provides Recommendations on Meningococcal Vaccination
Vaccination with MenACWY recommended for adolescents aged 11 to 12 years with booster at 16 years.
Vaccination with MenACWY recommended for adolescents aged 11 to 12 years with booster at 16 years.
The Centers for Disease Control and Prevention conducted a study to assess public familiarity of invasive fungal infections.
Findings based on large study of hospitalized patients in New York City early in the pandemic identifies AKI association with COVID-19 mortality.
Researchers assessed the serious infection risk for denosumab vs alendronate in real-world practice.
The aim of the study was to use real-world data to compare the risk of cardiac events in new users of azithromycin vs amoxicillin.
Some Michigan residents are being told to stay indoors after dark and protect themselves from mosquito bites.
Practices need to know all of the components of their health information systems to determine potential vulnerabilities.
In March 2020, compared with March 2019, there was an 80-fold increase in new prescriptions for hydroxychloroquine.
A high frequency of climate-change associated severe weather events have created an increased human-to-human transmission risk for novel diseases.
Genital mycotic infection is listed as a potential adverse effect of the SGLT2 inhibitor class.